Latest Insider Transactions at Adtran Inc (ADTN)
This section provides a real-time view of insider transactions for Adtran Inc (ADTN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ADTRAN INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ADTRAN INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2020
|
Kathryn A Walker |
BUY
Exercise of conversion of derivative security
|
Direct |
318
+0.85%
|
-
|
|
Dec 31
2020
|
Gregory James Mc Cray |
BUY
Grant, award, or other acquisition
|
Direct |
6,094
+16.15%
|
-
|
|
Dec 31
2020
|
Gregory James Mc Cray |
SELL
Sale (or disposition) back to the issuer
|
Direct |
0
|
$0
$14.77 P/Share
|
|
Dec 31
2020
|
Gregory James Mc Cray |
BUY
Exercise of conversion of derivative security
|
Direct |
318
+1.23%
|
-
|
|
Dec 31
2020
|
Hourigan Rice Jacqueline |
BUY
Grant, award, or other acquisition
|
Direct |
6,094
+50.0%
|
-
|
|
Dec 31
2020
|
Hourigan Rice Jacqueline |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
0
|
$0
$14.77 P/Share
|
|
Dec 31
2020
|
Hourigan Rice Jacqueline |
BUY
Exercise of conversion of derivative security
|
Indirect |
318
+1.08%
|
-
|
|
Dec 31
2020
|
Hourigan Rice Jacqueline |
BUY
Other acquisition or disposition
|
Indirect |
9,156
+24.12%
|
-
|
|
Dec 31
2020
|
Hourigan Rice Jacqueline |
SELL
Other acquisition or disposition
|
Direct |
9,156
-100.0%
|
-
|
|
Dec 01
2020
|
Marc Kimpe SVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.04%
|
$132
$12.86 P/Share
|
|
Dec 01
2020
|
Gregory James Mc Cray |
BUY
Grant, award, or other acquisition
|
Direct |
52
+0.21%
|
$624
$12.71 P/Share
|
|
Dec 01
2020
|
Ronald Centis SVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
2
+0.01%
|
$24
$12.85 P/Share
|
|
Dec 01
2020
|
Ray Harris Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2
+0.01%
|
$24
$12.85 P/Share
|
|
Dec 01
2020
|
Eduard Scheiterer SVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
19
+0.06%
|
$228
$12.71 P/Share
|
|
Nov 16
2020
|
Ronald Centis SVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
8,933
+28.9%
|
-
|
|
Nov 16
2020
|
Ray Harris Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,806
+30.54%
|
-
|
|
Nov 16
2020
|
Marc Kimpe SVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
7,153
+22.46%
|
-
|
|
Nov 16
2020
|
Michael Foliano Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,396
+16.6%
|
-
|
|
Nov 16
2020
|
Eduard Scheiterer SVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
10,239
+14.38%
|
-
|
|
Nov 16
2020
|
Thomas R Stanton Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
50,246
+15.46%
|
-
|
|
Nov 16
2020
|
James Denson Wilson Jr Chief Revenue Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,816
+22.08%
|
-
|
|
Nov 16
2020
|
Ray Harris Chief Information Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,270
-20.75%
|
$27,240
$12.39 P/Share
|
|
Nov 15
2020
|
Ronald Centis SVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
726
-5.27%
|
$8,712
$12.65 P/Share
|
|
Nov 15
2020
|
Thomas R Stanton Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,154
-2.67%
|
$73,848
$12.65 P/Share
|
|
Nov 15
2020
|
James Denson Wilson Jr Chief Revenue Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,086
-3.82%
|
$13,032
$12.65 P/Share
|
|
Nov 15
2020
|
Michael Foliano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,070
-3.73%
|
$12,840
$12.65 P/Share
|
|
Nov 15
2020
|
Eduard Scheiterer SVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
677
-2.98%
|
$8,124
$12.65 P/Share
|
|
Nov 15
2020
|
Marc Kimpe SVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
691
-3.79%
|
$8,292
$12.65 P/Share
|
|
Nov 12
2020
|
Thomas R Stanton Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,134
-0.92%
|
$25,608
$12.33 P/Share
|
|
Nov 12
2020
|
James Denson Wilson Jr Chief Revenue Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
475
-1.64%
|
$5,700
$12.33 P/Share
|
|
Nov 12
2020
|
Michael Foliano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
375
-1.29%
|
$4,500
$12.33 P/Share
|
|
Nov 12
2020
|
Eduard Scheiterer SVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
312
-1.35%
|
$3,744
$12.33 P/Share
|
|
Nov 12
2020
|
Marc Kimpe SVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
259
-1.4%
|
$3,108
$12.39 P/Share
|
|
Nov 11
2020
|
Eduard Scheiterer SVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
1,007
-1.72%
|
$12,084
$12.51 P/Share
|
|
Nov 11
2020
|
Thomas R Stanton Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,003
-0.85%
|
$24,036
$12.51 P/Share
|
|
Nov 11
2020
|
Michael Foliano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
327
-1.11%
|
$3,924
$12.51 P/Share
|
|
Nov 11
2020
|
James Denson Wilson Jr Chief Revenue Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
431
-1.47%
|
$5,172
$12.51 P/Share
|
|
Nov 11
2020
|
Marc Kimpe SVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
257
-1.37%
|
$3,084
$12.51 P/Share
|
|
Nov 09
2020
|
Thomas R Stanton Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,130
-1.32%
|
$34,430
$11.77 P/Share
|
|
Nov 09
2020
|
Michael Foliano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
511
-1.71%
|
$5,621
$11.77 P/Share
|
|
Nov 09
2020
|
James Denson Wilson Jr Chief Revenue Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
674
-2.24%
|
$7,414
$11.77 P/Share
|
|
Nov 09
2020
|
Eduard Scheiterer SVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
421
-1.77%
|
$4,631
$11.77 P/Share
|
|
Nov 09
2020
|
Marc Kimpe SVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
404
-2.11%
|
$4,444
$11.77 P/Share
|